Inventor
QURESHI ASAF A
US14 patents
⚠️ This page may combine multiple inventors who share the name “QURESHI ASAF A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIPOGENICS INC
7 patentsUS6239171B1May 29, 2001
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC86 citations98
US5591772AJan 7, 1997
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC123 citations98
US5919818AJul 6, 1999
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC83 citations96
US6143770ANov 7, 2000
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC53 citations95
US5821264AOct 13, 1998
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC57 citations95
US5908940AJun 1, 1999
Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds
LIPOGENICS INC86 citations93
US6204290B1Mar 20, 2001
Tocotrienols and tocotrienol-like compounds and methods for their use
LIPOGENICS INC24 citations92
RICEX COMPANY
3 patentsUS6126943AOct 3, 2000
Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
RICEX COMPANY45 citations94
US6733799B2May 11, 2004
Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
RICEX COMPANY27 citations90
US6558714B2May 6, 2003
Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
RICEX COMPANY19 citations90
BRISTOL MYERS SQUIBB CO
2 patentsUS5217992AJun 8, 1993
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
BRISTOL MYERS SQUIBB CO45 citations95
US5348974ASep 20, 1994
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
BRISTOL MYERS SQUIBB CO37 citations92